Funder
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science
Ministry of Education, Culture, Sports, Science and Technology
Takeda Pharmaceutical Company
Subject
Drug Discovery,Molecular Medicine
Reference42 articles.
1. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform;Bennett;Annu. Rev. Pharmacol. Toxicol.,2010
2. RNA therapeutics: beyond RNA interference and antisense oligonucleotides;Kole;Nat. Rev. Drug Discov.,2012
3. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial;Raal;Lancet,2010
4. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study;Finkel;Lancet,2016
5. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing;Nishina;Nat. Commun.,2015
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献